Q: Any thoughts on Chemtrade income fund? Latest results look ok to me.
5i Research Answer:
Revenue was well ahead of estimates but EPS did miss expectations. Income fell 12%. Revenue rose 6%. EBITDA rose 28%. Guidance was affirmed but does NOT include tariff impact. Debt is slowly coming down. The company is improving, but we would note that even so, its EPS this year is likely to be barely more than it was eight years ago. There has been little long term growth here. The stock is very cheap, but with a possible recession and tariffs we have to be cautious here in the short term.